We previously showed that supplementing SEP to breast cancer cells effectively suppressed PA production, while elevating NO synthesis and also downmodulating HER2 and cell proliferation to the levels similar to normal cells (12,18). This evidence concerns the gene ERBB2 and breast carcinoma.